Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
4.650
Zitationen
23
Autoren
2007
Jahr
Abstract
As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Ähnliche Arbeiten
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
2017 · 9.586 Zit.
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
2004 · 8.365 Zit.
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 · 8.274 Zit.
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 · 7.477 Zit.
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 · 7.046 Zit.
Autoren
- William E. Boden
- Robert A. O’Rourke
- Koon Teo
- Pamela Hartigan
- David J. Maron
- William J. Kostuk
- Merril L. Knudtson
- Marcin Dada
- Paul Casperson
- Crystal L. Harris
- Bernard Chaitman
- Leslee J. Shaw
- Gilbert Gosselin
- Shah Nawaz
- Lawrence Title
- Gerald T. Gau
- Alvin Blaustein
- David C. Booth
- Eric Bates
- John A. Spertus
- Daniel S. Berman
- G.B. John Mancini
- William S. Weintraub